Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial

References

• Kim DR, Duprez F, Werbrouck J, et al. A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique. Radiother Oncol. 2013;107(3):295–299.
   PubMed Web of Science ®Google Scholar
• Murphy BA. Late treatment effects: reframing the questions. Lancet Oncol. 2009;10(6):530–531.
   PubMed Web of Science ®Google Scholar
• Werbrouck J, De Ruyck K, Duprez F, et al. Acute normal tissue reactions in head-and-Neck cancer patients treated with IMRT: Influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys. 2009;73(4):1187–1195.
   PubMed Web of Science ®Google Scholar
• Wang X, Eisbruch A. IMRT for head and neck cancer: reducing xerostomia and dysphagia. J Radiat Res. 2016;57(S1):i69–i75.
   PubMed Web of Science ®Google Scholar
• Petkar I, Bhide S, Newbold K, et al. Dysphagia-optimised intensity-modulated radiotherapy techniques in pharyngeal cancers: is anyone going to swallow it? Clin Oncol (R Coll Radiol). 2017;29(7):e110–e118.
   PubMed Web of Science ®Google Scholar
• Christianen MEMC, Langendijk JA, Westerlaan HE, et al. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol. 2011;101(3):394–402.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events v.4.0 (CTCAE). Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.
   Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–1346.
   PubMed Web of Science ®Google Scholar
• Hutcheson KA, Barrow MP, Barringer DA, et al. Dynamic imaging grade of swallowing toxicity (DIGEST): scale development and validation. Cancer. 2017;123(1):62–70. 2016/08/26.
   PubMed Web of Science ®Google Scholar
• Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010;28(16):2732–2738.
   PubMed Web of Science ®Google Scholar
• Roe JWG, Drinnan MJ, Carding PN, et al. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia? Oral Oncol. 2014;50(12):1182–1187.
   PubMed Web of Science ®Google Scholar
• Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24(17):2636–2643.
   PubMed Web of Science ®Google Scholar
• Popovtzer A, Cao Y, Feng FY, et al. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose–effect relationships: MRI-based study. Radiother Oncol. 2009;93(3):510–515.
   PubMed Web of Science ®Google Scholar
• Van Der Laan HP, Christianen MEMC, Bijl HP, et al. The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study. Radiother Oncol. 2012;103(1):76–81.
   PubMed Web of Science ®Google Scholar
• Petkar I, Rooney K, Roe JWG, et al. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer. 2016;16(1):1–10.
   Web of Science ®Google Scholar
• Van Der Laan HP, Gawryszuk A, Christianen MEMC, et al. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction. Radiother Oncol. 2013;107(3):282–287.
   PubMed Web of Science ®Google Scholar
• Christianen MEMC, Van Der Schaaf A, Van Der Laan HP, et al. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach. Radiother Oncol. 2016;118(2):298–303.
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425–1439.
   PubMed Web of Science ®Google Scholar
• Feng FY, Kim HM, Lyden TH, et al. Intensity-Modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68(5):1289–1298.
   PubMed Web of Science ®Google Scholar
• Dirix P, Abbeel S, Vanstraelen B, et al. Dysphagia after chemoradiotherapy for head-and-Neck squamous cell carcinoma: Dose-Effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2009;75(2):385–392.
   PubMed Web of Science ®Google Scholar
• Caudell JJ, Burnett OL, Schaner PE, et al. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer. Int J Radiat Oncol Biol Phys. 2010;77(2):462–467.
   PubMed Web of Science ®Google Scholar
• Christianen MEMC, Schilstra C, Beetz I, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2012;105(1):107–114.
   PubMed Web of Science ®Google Scholar
• Mortensen HR, Overgaard J, Jensen K, et al. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol. 2013;52(7):1535–1542.
   PubMed Web of Science ®Google Scholar
• Mortensen HR, Jensen K, Aksglaede K, et al. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiother Oncol. 2013;107(3):288–294.
   PubMed Web of Science ®Google Scholar
• Graff P, Woisard V, Racadot S, et al. Radiothérapie conformationnelle avec modulation d’intensité des cancers des voies aérodigestives supérieures: dose de tolérance des tissus sains. Muscles constricteurs du pharynx et larynx. Cancer/Radiothérapie. 2016;20(6-7):452–458.
   Google Scholar
• Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol. 2007;85(1):74–82.
   PubMed Web of Science ®Google Scholar
• Caglar HB, Tishler RB, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72(4):1110–1118.
   PubMed Web of Science ®Google Scholar